Trump busted for claiming he will reduce drug prices while rolling back a policy that increases

WASHINGTON - The Trump administration on Thursday boldly reversed an Obama-era policy that supporters said had helped lower prices for some costly drugs. The policy centers on so-called biosimilar drugs, which are highly similar versions of biologic drugs manufactured in living cells or microorganisms.